在各种炎症性疾病中,catalpol的抗炎作用和机制
Jinyao Liu1, Shuang Liu1, Mingyue Yu1
1Department of Endodontics, Hospital of Stomatology, Jilin University, Changchun, China.
Drug development research
|August 3, 2023
概括
卡塔尔波尔 (Catalpol) 是来自Rehmannia的虹膜糖化物,在许多疾病中表现出显著的抗炎作用. 这篇评论详细介绍了其在抗炎的机制.
科学领域:
- 药理学 药理学是指药理学的学科.
- 自然产品 自然产品
- 免疫学 免疫学 免疫学
背景情况:
- 卡塔尔波尔 (Catalpol) 是一种在各种植物中发现的虹膜糖化物,尤其是药用草药雷曼尼亚.
- 它具有多样化的生物活性,包括抗炎,抗氧化和抗瘤特性.
- 之前的研究表明,catalpol在治疗炎症方面具有潜力.
研究的目的:
- 在过去十年中全面审查了catalpol抗炎作用的文献.
- 阐明catalpol抗炎作用的具体机制.
- 巩固目前关于catalpol在炎症疾病中的治疗潜力的知识.
主要方法:
- 在科学数据库 (如PubMed,Scopus) 中进行系统的文献搜索.
- 对调查catalpol在各种炎症疾病模型中的疗效的研究进行分析.
- 专注于详细研究分子和细胞作用机制的研究.
主要成果:
- 在神经,心血管,脏,呼吸道,消化系统,骨和关节,眼睛和牙周疾病中,Catalpol表现出强大的抗炎作用.
- 关键机制包括对炎症信号通路 (例如NF-κB,MAPK) 的调节,减少促炎细胞因子和抗氧化活性.
- 有证据支持catalpol在抑制炎症细胞透和活动方面的作用.
结论:
- 卡塔尔波尔是一种有前途的天然化合物,具有广泛的抗炎活性.
- 了解它的机制为开发新的治疗策略提供了基础.
- 需要进一步的研究来将这些发现转化为炎症性疾病的临床应用.
相关概念视频
01:28Inflammatory Response
2.1K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
2.1K
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
173
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
173
01:29Drugs for Treatment of Ulcerative Colitis in IBD
175
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
175
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
153
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
153
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
195
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
195
01:29Inflammatory Bowel Disease IV: Pharmacological Management
152
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
152